Literature DB >> 12706234

Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells.

Pratima Sur1, Eric Anthony Sribnick, James Michael Wingrave, Mark Walter Nowak, Swapan Kumar Ray, Naren Lal Banik.   

Abstract

We examined the mechanism of 17beta-estradiol (estrogen)-mediated inhibition of apoptosis in C6 (rat glioma) cells following exposure to hydrogen peroxide (H(2)O(2)). Cells were preincubated with 4 microM estrogen for 2 h and then exposed to 100 microM H(2)O(2) for 24 h. Exposure to H(2)O(2) caused significant increases in intracellular calcium (Ca(2+)), as determined by fura-2, which was attenuated by preincubation with estrogen. H(2)O(2) and ionomycin caused cell death in a dose-dependent manner, as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Preincubation with estrogen restored viability in cells exposed to H(2)O(2) but not in cells exposed to ionomycin. Western blot analysis showed an increase in Bax/Bcl-2 ratio, calpain activity, and caspase-3 activity following treatment with H(2)O(2), and estrogen pretreatment decreased levels of all three. Cell morphology, as evaluated by Wright staining, indicated apoptosis in cells treated with H(2)O(2), and pretreatment with estrogen reduced apoptosis. Results from MTT and Wright staining were further supported by the terminal deoxyribonucleotidyl transferase (TdT)-mediated dUTP Nick End Labeling (TUNEL) assay. These results indicate a role for estrogen in preventing apoptosis in C6 glial cells exposed to H(2)O(2). Our results suggest that estrogen may have a protective role in minimizing glial cell apoptosis in neurological diseases such as demyelinating disease or central nervous system trauma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706234     DOI: 10.1016/s0006-8993(03)02349-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

Review 1.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

2.  Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study.

Authors:  Lene Andersen; Søren Friis; Jesper Hallas; Pernille Ravn; Bjarne W Kristensen; David Gaist
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

3.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

4.  Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.

Authors:  S-Y Park; C Tournell; R C Sinjoanu; A Ferreira
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

5.  Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.

Authors:  Sarah A Imam; Mary K Guyton; Azizul Haque; Arthur Vandenbark; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

6.  Methylprednisolone and indomethacin inhibit oxidative stress mediated apoptosis in rat C6 glioblastoma cells.

Authors:  Arabinda Das; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

7.  Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Authors:  Wei Yao; Weiwei Dai; Mohammad Shahnazari; Aaron Pham; Zhiqiang Chen; Haiyan Chen; Min Guan; Nancy E Lane
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

8.  Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels.

Authors:  Eric A Sribnick; Angelo M Del Re; Swapan K Ray; John J Woodward; Naren L Banik
Journal:  Brain Res       Date:  2009-04-21       Impact factor: 3.252

9.  Estrogen treatment in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  J Neurol Sci       Date:  2009-06-18       Impact factor: 3.181

10.  Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats.

Authors:  Eric A Sribnick; Supriti Samantaray; Arabinda Das; Joshua Smith; D Denise Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.